We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

169 hedge funds and large institutions have $282M invested in Spectrum Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

1% more funds holding

Funds holding: 167 → 169 (+2)

2% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 51

8% less call options, than puts

Call options by funds: $5.65M | Put options by funds: $6.12M

60% less capital invested

Capital invested by funds: $708M → $282M (-$426M)

Holders
169
Holders Change
+2
Holders Change %
+1.2%
% of All Funds
3.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
52
Reduced
51
Closed
21
Calls
$5.65M
Puts
$6.12M
Net Calls
-$470K
Net Calls Change
+$9.68M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.99M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$6.2M
3
BlackRock
BlackRock
New York
+$5.07M
4
Morgan Stanley
Morgan Stanley
New York
+$4.02M
5
State Street
State Street
Massachusetts
+$4.02M

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$36.8M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$28.9M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$7.64M
4
SIM
Sonora Investment Management
Arizona
-$5.72M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$68.6M +$5.07M +627,538 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$49.3M +$6.2M +767,600 +6%
Primecap Management
3
Primecap Management
California
$23.4M -$36.8M -4,559,800 -42%
State Street
4
State Street
Massachusetts
$17.6M +$4.02M +497,048 +11%
Renaissance Technologies
5
Renaissance Technologies
New York
$10.2M +$309K +38,283 +1%
Macquarie Group
6
Macquarie Group
Australia
$10M -$5.17M -639,483 -19%
Norges Bank
7
Norges Bank
Norway
$8.82M – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.61M +$570K +70,544 +5%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$5.57M +$1.75M +216,213 +16%
Northern Trust
10
Northern Trust
Illinois
$5.37M +$259K +32,022 +2%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$5.07M -$5.46M -675,899 -33%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$4.59M +$369K +45,687 +4%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$4.5M +$9.99M +1,236,493 New
ACH
14
ArrowMark Colorado Holdings
Colorado
$3.91M -$28.9M -3,571,279 -77%
Morgan Stanley
15
Morgan Stanley
New York
$3.78M +$4.02M +497,858 +92%
CS
16
Candriam SCA
Luxembourg
$3.61M -$214K -26,518 -3%
Principal Financial Group
17
Principal Financial Group
Iowa
$3.36M +$824 +102 +0%
Goldman Sachs
18
Goldman Sachs
New York
$2.6M +$2.39M +295,196 +70%
Charles Schwab
19
Charles Schwab
California
$2.51M +$117K +14,458 +2%
Invesco
20
Invesco
Georgia
$2.4M -$84.7K -10,486 -2%
Wells Fargo
21
Wells Fargo
California
$2.27M -$598K -74,044 -11%
Ameriprise
22
Ameriprise
Minnesota
$2.12M -$120K -14,910 -2%
N
23
Nuveen
North Carolina
$2.09M +$860K +106,487 +23%
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$1.31M +$192K +23,726 +7%
Legal & General Group
25
Legal & General Group
United Kingdom
$1.23M +$332K +41,143 +14%
1
2 3 4 5

SPPI Hedge Fund Activity: Q4 2019 in Review

169 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2019, worth a combined $282M — down 60% from $708M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 21 closed out — a net gain of 8 holders — while 52 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $9.99M. The largest seller was Primecap Management, cutting an estimated $36.8M.

  • 169 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $282M of Spectrum Pharmaceuticals Inc stock for Q4 2019, down 60% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2019 and 21 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2019 was Wellington Management Group, an estimated $9.99M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2019 was Primecap Management, an estimated $36.8M sold.

Based on aggregated 13F filings for Q4 2019.